SALADINI FRANCESCO | Elenco docenti

Giammarino, F., Paletti, C., Bartolini, N., Fiaschi, L., Biba, C., Varasi, I., et al. (2025). Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro. ANTIVIRAL RESEARCH, 239 [10.1016/j.antiviral.2025.106157]. - dettaglio
Panza, F., Saladini, F., Bartolini, N., Gianmarino, F., Montagnani, F., Spagnuolo, V., et al. (2024). PRESTIGIO RING “a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests”. NEW MICROBIOLOGICA, 47(1), 116-122. - dettaglio
Monti, B., Soria, A., Saladini, F., Lapadula, G., Squillace, N., Giammarino, F., et al. (2024). Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests. JOURNAL OF MEDICAL VIROLOGY, 96(8) [10.1002/jmv.29832]. - dettaglio
Giammarino, F., de Salazar, A., Malet, I., Vinuela, L., Fuentes, A., Saladini, F., et al. (2024). Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes. THE JOURNAL OF INFECTIOUS DISEASES, 229(6), 1796-1802 [10.1093/infdis/jiae010]. - dettaglio
Armenia, D., Carioti, L., Micheli, V., Bon, I., Allice, T., Bonura, C., et al. (2024). Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy. VIRUSES, 16(9) [10.3390/v16091422]. - dettaglio

Tutte le pubblicazioni